Alvotech Statistics
NASDAQ: ALVOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
5.67-0.18 (-3.08%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Alvotech by the numbers
Alvotech has a market capitalization of $2.02 billion based on 356.82M shares outstanding. With trailing EPS of $-0.62, Alvotech is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.5% above its 50-day average and 35.0% above its 200-day average.
Average daily trading volume is 1.05M shares, or about $5.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ALVO valuation vs. peer median
| Metric | ALVO | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.02B | $2.00B | +1% |
| Forward P/E | 24.8 | 11.0 | +127% |
| Avg. volume | 1.05M | 2.28M | -54% |
Peer median across 8 companies: RXRX, BCRX, VIR, NVAX, MESO, ADMA, BEAM, IMCR.
Valuation
- Market cap
- $2.02B
- Forward P/E
- 24.83
- EPS (TTM)
- $-0.62
- Shares outstanding
- 356.82M
Price and trading
- Previous close
- 5.85
- Open
- 5.83
- Day range
- 5.61 – 5.83
- 52-week range
- 2.94 – 9.05
- 52-week change
- -34.68%
- Beta
- —
- Volume
- 668.88K
- Average volume
- 1.05M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 11, 2026
Additional statistics
- Market Cap
- 2.02B
- Forward Pe
- 24.83
- Eps
- -0.62
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.05
- Week52 Low
- 2.94
- Avg Volume
- 1.05M
- Shares Outstanding
- 356.82M
- Ma50
- 4.95
- Ma200
- 4.20
- Earnings Date
- Nov 11, 2026
- Pct From52w High
- -37.31%
- Pct From52w Low
- 92.86%